MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Pharmaceutical Economics and Policy
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,682 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,682 works in the cohort · of 4,299,418page 16 of 34

Labels cover 5 of 1,682 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,682 of 1,682 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

aboutno affunlabeled
Abbott Laboratories
2007· article· en· Mergent s Dividend Achievers· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · none
2
citations
affunlabeled
Tifacogin (Chiron Corp/Pharmacia Corp).
Niv Sne, Hari Kumar Ondiveeran, Alison Fox‐Robichaud
2002· article· en· PubMed· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
fundaboutno affunlabeled
Do high drug prices fund pharmaceutical innovation?
William Lazonick, Öner Tulum
2024· article· en· Healthcare Management Forum· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
venueaboutno affunlabeled
Reforming Canada's Access to Medicines Regime
Laura Esmail
2007· letter· en· Canadian Medical Association Journal· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Abbott Laboratories
2008· article· en· Mergent s Dividend Achievers· Economics, Econometrics and Finance
machine prediction:candidate · insufficient_payloadconsensus · none
2
citations
aboutno affunlabeled
Multimarket Contact in Pharmaceutical Markets
Javier Coronado, Sergi Jimenez-Mart, Pedro L. Mar
2007· preprint· en· RECERCAT (Consorci de Serveis Universitaris de Catalunya)· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
affvenueaboutunlabeled
Drugs, Health and the Economy: Investment, Innovation, Outcomes, Growth
Terrence J. Montague, Siobhan Cavanaugh, Kevin Skilton, Gregg Szabo, Jeff Sidel, Jean‐Pierre Grégoire
2002· review· en· A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Lowering the High Cost of Cancer Drugs—III
Amir Attaran, Tim K. Mackey, Reed F. Beall
2016· letter· en· Mayo Clinic Proceedings· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Just the berries: Nephrotoxic drugs.
Tom Hewlett
2004· article· en· PubMed· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Compulsory Licenses: The Authors Reply
Reed F. Beall, Amir Attaran, Randall Kuhn
2015· letter· en· Health Affairs· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
venueno affno abstractunlabeled
Drugs of Choice: a Formulary for General Practice
Janice Irvine-Meek
2000· article· en· The Canadian Journal of Hospital Pharmacy· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
aboutno affunlabeled
Drug Shortages in Perioperative Medicine
Gildàsio S. De Oliveira, Robert J. McCarthy
2015· letter· en· Anesthesia & Analgesia· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
2
citations
← previousnext →

How this was built: Screen · Findings · About